Trv Gp V, LLC 13F holdings
Trv Gp V, LLC reported 3 positions with a total reported value of $498.2M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-10. Top holdings by reported value: RAPP RAPPORT THERAPEUTICS, INC. (52.5%), SEPN SEPTERNA, INC. (41.8%), MAZE MAZE THERAPEUTICS, INC. (5.7%). Against 2026-03-31 it opened 0 new positions and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Trv Gp V, LLC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
3 largest of 3 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| RAPP RAPPORT THERAPEUTICS, INC. | 6,280,525 | $261.7M | 52.5% |
| SEPN SEPTERNA, INC. | 6,215,591 | $208.2M | 41.8% |
| MAZE MAZE THERAPEUTICS, INC. | 950,800 | $28.4M | 5.7% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 0 in all · reported value as of 2026-06-30
No new positions.
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 0 in all · reported value as of 2026-03-31
No positions were sold out.
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
No position was increased.
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| RAPP RAPPORT THERAPEUTICS, INC. | 7,135,233 | 6,280,525 | -12.0% | $261.7M |
CIK 1990717 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
